Works by Ailawadhi, Sikander

Results: 154
    1
    2
    3
    4
    5
    6
    7
    8

    Impact of early detection on cancer curability: A modified Delphi panel study.

    Published in:
    PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0279227
    By:
    • Schwartzberg, Lee;
    • Broder, Michael S.;
    • Ailawadhi, Sikander;
    • Beltran, Himisha;
    • Blakely, L. Johnetta;
    • Budd, G. Thomas;
    • Carr, Laurie;
    • Cecchini, Michael;
    • Cobb, Patrick;
    • Kansal, Anuraag;
    • Kim, Ashley;
    • Monk, Bradley J.;
    • Wong, Deborah J.;
    • Campos, Cynthia;
    • Yermilov, Irina
    Publication type:
    Article
    9
    10
    11
    12

    Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
    By:
    • Chohan, Karan L.;
    • Paludo, Jonas;
    • Vallumsetla, Nishanth;
    • Larson, Dirk;
    • King, Rebecca L.;
    • He, Rong;
    • Gonsalves, Wilson;
    • Inwards, David;
    • Witzig, Thomas E.;
    • Swaika, Abhisek;
    • Jain, Tania;
    • Leung, Nelson;
    • Ailawadhi, Sikander;
    • Reeder, Craig B.;
    • Lacy, Martha Q.;
    • Rajkumar, S. Vincent;
    • Kumar, Shaji;
    • Kyle, Robert A.;
    • Gertz, Morie A.;
    • Ansell, Stephen M.
    Publication type:
    Article
    13

    Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 49, doi. 10.1002/ajh.26762
    By:
    • Ho, Matthew;
    • Zanwar, Saurabh;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan‐Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    14

    Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Muchtar, Eli;
    • He, Rong;
    • Greipp, Patricia T.;
    • King, Rebecca L.;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy T.;
    • Habermann, Thomas M.;
    • Inwards, David;
    • Go, Ronald S.;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie A.;
    • Witzig, Thomas E.;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    15

    Connect MM Registry as a national reference for United States multiple myeloma patients.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 1, p. 35, doi. 10.1002/cam4.2656
    By:
    • Ailawadhi, Sikander;
    • Jagannath, Sundar;
    • Narang, Mohit;
    • Rifkin, Robert M.;
    • Terebelo, Howard R.;
    • Toomey, Kathleen;
    • Durie, Brian G. M.;
    • Hardin, James W.;
    • Gasparetto, Cristina J.;
    • Wagner, Lynne;
    • Omel, James L.;
    • Kumar, Vivek;
    • Yue, Lihua;
    • Kitali, Amani;
    • Agarwal, Amit;
    • Abonour, Rafat
    Publication type:
    Article
    16
    17
    18

    Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis.

    Published in:
    Cancer Medicine, 2017, v. 6, n. 12, p. 2876, doi. 10.1002/cam4.1246
    By:
    • Ailawadhi, Sikander;
    • Frank, Ryan D.;
    • Advani, Pooja;
    • Swaika, Abhisek;
    • Temkit, M'hamed;
    • Menghani, Richa;
    • Sharma, Mayank;
    • Meghji, Zahara;
    • Paulus, Shumail;
    • Khera, Nandita;
    • Hashmi, Shahrukh K.;
    • Paulus, Aneel;
    • Kakar, Tanya S.;
    • Hodge, David O.;
    • Colibaseanu, Dorin T.;
    • Vizzini, Michael R.;
    • Roy, Vivek;
    • Colon‐Otero, Gerardo;
    • Chanan‐Khan, Asher A.
    Publication type:
    Article
    19

    Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01177-6
    By:
    • Ailawadhi, Sikander;
    • Lee, Hans C.;
    • Omel, James;
    • Toomey, Kathleen;
    • Hardin, James W.;
    • Gasparetto, Cristina J.;
    • Jagannath, Sundar;
    • Rifkin, Robert M.;
    • Durie, Brian G. M.;
    • Narang, Mohit;
    • Terebelo, Howard R.;
    • Joshi, Prashant;
    • Jou, Ying-Ming;
    • Mouro, Jorge;
    • Yu, Edward;
    • Abonour, Rafat
    Publication type:
    Article
    20
    21
    22

    Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01081-z
    By:
    • Rees, Matthew J.;
    • Mammadzadeh, Aytaj;
    • Bolarinwa, Abiola;
    • Elhaj, Mohammed E.;
    • Bohra, Arwa;
    • Bansal, Radhika;
    • Ailawadhi, Sikander;
    • Parrondo, Ricardo;
    • Chhabra, Saurabh;
    • Khot, Amit;
    • Hayman, Suzanne;
    • Dispenzieri, Angela;
    • Buadi, Francis;
    • Dingli, David;
    • Warsame, Rahma;
    • Kapoor, Prashant;
    • Gertz, Morie A.;
    • Muchtar, Eli;
    • Kourelis, Taxiarchis;
    • Gonsalves, Wilson
    Publication type:
    Article
    23
    24
    25

    Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
    By:
    • Bansal, Radhika;
    • Baksh, Mizba;
    • Larsen, Jeremy T.;
    • Hathcock, Matthew A.;
    • Dingli, David;
    • Stewart, A. Keith;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.;
    • Warsame, Rahma M.;
    • Fonseca, Rafael;
    • Bergsagel, P. Leif;
    • Ailawadhi, Sikander;
    • Kumar, Shaji K.;
    • Lin, Yi
    Publication type:
    Article
    26

    Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00805-x
    By:
    • Moreau, Philippe;
    • Chari, Ajai;
    • Oriol, Albert;
    • Martinez-Lopez, Joaquin;
    • Haenel, Mathias;
    • Touzeau, Cyrille;
    • Ailawadhi, Sikander;
    • Besemer, Britta;
    • de la Rubia Comos, Javier;
    • Encinas, Cristina;
    • Mateos, Maria-Victoria;
    • Salwender, Hans;
    • Rodriguez-Otero, Paula;
    • Hulin, Cyrille;
    • Karlin, Lionel;
    • Sureda Balari, Anna;
    • Bargay, Joan;
    • Benboubker, Lotfi;
    • Rosiñol, Laura;
    • Tarantolo, Stefano
    Publication type:
    Article
    27

    Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
    By:
    • Bansal, Radhika;
    • Baksh, Mizba;
    • Larsen, Jeremy T.;
    • Hathcock, Matthew A.;
    • Dingli, David;
    • Stewart, A. Keith;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.;
    • Warsame, Rahma M.;
    • Fonseca, Rafael;
    • Bergsagel, P. Leif;
    • Ailawadhi, Sikander;
    • Kumar, Shaji K.;
    • Lin, Yi
    Publication type:
    Article
    28

    Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

    Published in:
    2023
    By:
    • Moreau, Philippe;
    • Chari, Ajai;
    • Oriol, Albert;
    • Martinez-Lopez, Joaquin;
    • Haenel, Mathias;
    • Touzeau, Cyrille;
    • Ailawadhi, Sikander;
    • Besemer, Britta;
    • de la Rubia Comos, Javier;
    • Encinas, Cristina;
    • Mateos, Maria-Victoria;
    • Salwender, Hans;
    • Rodriguez-Otero, Paula;
    • Hulin, Cyrille;
    • Karlin, Lionel;
    • Sureda Balari, Anna;
    • Bargay, Joan;
    • Benboubker, Lotfi;
    • Rosiñol, Laura;
    • Tarantolo, Stefano
    Publication type:
    Letter
    29

    Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00752-z
    By:
    • Zanwar, Saurabh;
    • Ho, Matthew;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan-Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    30
    31

    Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00721-6
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Ailawadhi, Sikander;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Sher, Taimur;
    • Hanson, Curtis A.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    32
    33

    Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00680-y
    By:
    • Parrondo, Ricardo D.;
    • Rahman, Zaid Abdel;
    • Heckman, Michael G.;
    • Wieczorek, Mikolaj;
    • Jiang, Liuyan;
    • Alkhateeb, Hassan B.;
    • Litzow, Mark R.;
    • Greipp, Patricia;
    • Sher, Taimur;
    • Bergsagel, Leif;
    • Fonseca, Rafael;
    • Roy, Vivek;
    • Dispenzieri, Angela;
    • Kharfan-Dabaja, Mohamed A.;
    • Murthy, Hemant S.;
    • Ailawadhi, Sikander;
    • Foran, James M.
    Publication type:
    Article
    34
    35
    36
    37

    Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 10, p. N.PAG, doi. 10.1038/s41408-019-0237-1
    By:
    • Kumar, Vivek;
    • Ailawadhi, Sikander;
    • Bojanini, Leyla;
    • Mehta, Aditya;
    • Biswas, Suman;
    • Sher, Taimur;
    • Roy, Vivek;
    • Vishnu, Prakash;
    • Marin-Acevedo, Julian;
    • Alegria, Victoria R.;
    • Paulus, Aneel;
    • Aulakh, Sonikpreet;
    • Iqbal, Madiha;
    • Manochakian, Rami;
    • Tan, Winston;
    • Chanan-Khan, Asher;
    • Ailawadhi, Meghna
    Publication type:
    Article
    38
    39
    40

    The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31430-0
    By:
    • Vo, Josh N.;
    • Wu, Yi-Mi;
    • Mishler, Jeanmarie;
    • Hall, Sarah;
    • Mannan, Rahul;
    • Wang, Lisha;
    • Ning, Yu;
    • Zhou, Jin;
    • Hopkins, Alexander C.;
    • Estill, James C.;
    • Chan, Wallace K. B.;
    • Yesil, Jennifer;
    • Cao, Xuhong;
    • Rao, Arvind;
    • Tsodikov, Alexander;
    • Talpaz, Moshe;
    • Cole, Craig E.;
    • Ye, Jing C.;
    • Multiple Myeloma Research Consortium;
    • Ailawadhi, Sikander
    Publication type:
    Article
    41
    42

    Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial.

    Published in:
    Leukemia & Lymphoma, 2009, v. 50, n. 7, p. 1096, doi. 10.1080/10428190902912460
    By:
    • Chanan-Khan, Asher;
    • Miller, Kena C.;
    • Musial, Laurie;
    • Padmanabhan, Swaminathan;
    • Yu, Jihnhee;
    • Ailawadhi, Sikander;
    • Sher, Taimur;
    • Mohr, Alice;
    • Bernstein, Zale P.;
    • Barcos, Maurice;
    • Patel, Mehul;
    • Iancu, Dan;
    • Lee, Kelvin;
    • Czuczman, Myron S.
    Publication type:
    Article
    43
    44
    45

    P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI‐CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970564.52503.e2
    By:
    • Abonour, Rafat;
    • Rifkin, Robert;
    • Ailawadhi, Sikander;
    • Lee, Hans C.;
    • Gasparetto, Christina;
    • Wagner, Lynne;
    • Durie, Brian;
    • Hardin, James;
    • Terebelo, Howard;
    • Narang, Mohit;
    • Toomey, Kathleen;
    • Tang, Yuexin;
    • Dhanasiri, Sujith;
    • Anand, Jasmeet;
    • Yu, Edward;
    • Marshall, Thomas;
    • Liu, Liang;
    • Jagannath, Sundar
    Publication type:
    Article
    46

    P905: PATIENT REPORTED OUTCOMES IN TRIPLE CLASS EXPOSED, RELAPSED/REFRACTORY MULTIPLE MYELOMA (TCE RRMM) PATIENTS IN KARMMA 3 TRIAL (PHASE 3 RCT): IDECABTAGENE VICLEUCEL (IDE‐CEL) VERSUS STANDARD REGIMENS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970524.03100.9e
    By:
    • Delforge, Michel;
    • Patel, Krina;
    • Eliason, Laurie;
    • Dhanda, Devender;
    • Shi, Ling;
    • Guo, Shien;
    • Marshall, Thomas;
    • Arnulf, Bertrand;
    • Cavo, Michele;
    • Nooka, Ajay;
    • Manier, Salomon;
    • Callander, Natalie;
    • Giralt, Sergio;
    • Einsele, Hermann;
    • Ailawadhi, Sikander;
    • Popa Mckiver, Mihaela;
    • Cook, Mark;
    • Rodríguez‐Otero, Paula
    Publication type:
    Article
    47

    P866: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): KARMMA-3 SUBGROUP ANALYSIS BY PRIOR LINES OF THERAPY.

    Published in:
    2023
    By:
    • Manier, Salomon;
    • Rodríguez-Otero, Paula;
    • Mateos, Maria-Victoria;
    • Einsele, Hermann;
    • Bahlis, Nizar J;
    • Munshi, Nikhil;
    • Ailawadhi, Sikander;
    • Arnulf, Bertrand;
    • Nooka, Ajay;
    • Vij, Ravi;
    • Weum Abrahamsen, Ingerid;
    • Broijl, Annemiek;
    • Jagannath, Sundar;
    • Benjamin, Reuben;
    • Gergis, Usama;
    • Sborov, Douglas W.;
    • Iida, Shinsuke;
    • Truppel-Hartmann, Anna;
    • Yang, Zhihong;
    • Piasecki, Julia
    Publication type:
    Abstract
    48
    49
    50

    Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma.

    Published in:
    Leukemia & Lymphoma, 2024, v. 65, n. 12, p. 1789, doi. 10.1080/10428194.2024.2373331
    By:
    • Dimopoulos, Meletios A.;
    • Migkou, Magdalini;
    • Bhutani, Manisha;
    • Ailawadhi, Sikander;
    • Kalff, Anna;
    • Walcott, Farzana L.;
    • Pore, Nabendu;
    • Brown, Miranda;
    • Wang, Fujun;
    • Cheng, Lily I.;
    • Kagiampakis, Ioannis;
    • Williams, Marna;
    • Kinneer, Krista;
    • Wu, Yuling;
    • Jiang, Yu;
    • Kubiak, Robert J.;
    • Zonder, Jeffrey A.;
    • Larsen, Jeremy;
    • Sirdesai, Shreerang;
    • Yee, Andrew J.
    Publication type:
    Article